AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionOperose Advisors LLC
Latest Disclosed Ownership4,825 shares
Latest Disclosed Value $ 1,049,390
Operose Advisors LLC reports 8.06% increase in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - Operose Advisors LLC filed a 13F-HR form disclosing ownership of 4,825 shares of AbbVie Inc. (BG:4AB) valued at $1,049,390 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 4,465 shares of AbbVie Inc.. This represents a change in shares of 8.06% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AbbVie COMMON 00287Y109 4,825 360 8.06 1,049 2.84 0.2433
2026-02-10 2025-12-31 13F AbbVie COMMON 00287Y109 4,465 0 0.00 1,020 -1.26 0.2377
2025-11-12 2025-09-30 13F AbbVie COMMON 00287Y109 4,465 0 0.00 1,034 24.76 0.2577
2025-08-14 2025-06-30 13F AbbVie COMMON 00287Y109 4,465 0 0.00 829 -11.44 0.2337
2025-05-12 2025-03-31 13F AbbVie COMMON 00287Y109 4,465 -1,106 -19.85 936 -5.46 0.3099
2025-02-13 2024-12-31 13F AbbVie COMMON 00287Y109 5,571 1,204 27.57 990 14.73 0.3387
2024-11-13 2024-09-30 13F AbbVie COMMON 00287Y109 4,367 34 0.78 862 16.02 0.2789
2024-08-08 2024-06-30 13F AbbVie COMMON 00287Y109 4,333 -250 -5.45 743 -10.91 0.2632
2024-05-13 2024-03-31 13F AbbVie COMMON 00287Y109 4,583 2,630 134.66 835 176.16 0.2819
2024-02-12 2023-12-31 13F AbbVie COMMON 00287Y109 1,953 -467 -19.30 303 -16.11 0.1211
2023-11-13 2023-09-30 13F AbbVie COMMON 00287Y109 2,420 834 52.59 361 69.01 0.1429
2023-08-09 2023-06-30 13F AbbVie COMMON 00287Y109 1,586 0 0.00 214 -15.48 0.0968
2023-05-09 2023-03-31 13F AbbVie COMMON 00287Y109 1,586 -549 -25.71 253 -26.96 0.1256
2023-02-13 2022-12-31 13F AbbVie COMMON 00287Y109 2,135 549 34.62 345 61.97 0.1843
2022-11-14 2022-09-30 13F AbbVie COMMON 00287Y109 1,586 136 9.38 213 -4.05 0.1399
2022-08-11 2022-06-30 13F AbbVie COMMON 00287Y109 1,450 0 0.00 222 -5.53 0.1561
2022-05-12 2022-03-31 13F AbbVie COMMON 00287Y109 1,450 0 0.00 235 19.90 0.1624
2022-02-14 2021-12-31 13F AbbVie Common 00287Y109 1,450 1,450 196 0.1595
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.